These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2285202

  • 1. [Pharmacokinetic parameters of prednisone and prednisolone in healthy volunteers].
    Etienne SD, Vandermeersch V, Chosidow O, Vu-Thi-My-Le C, Godeau P, Diquet B, Herson S.
    Ann Med Interne (Paris); 1990; 141(6):507-11. PubMed ID: 2285202
    [Abstract] [Full Text] [Related]

  • 2. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
    Kamada AK, Wiener MB, LaVallee NM, Scott MB, Selner JC, Szefler SJ.
    Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM, Walker C, Frey FJ, de Weck AL.
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [Abstract] [Full Text] [Related]

  • 4. [Comparative bioavailability of prednisolone metasulfobenzoate with prednisolone].
    Flouvat B, Molinier P, Dellatolas F.
    Therapie; 1994 Nov; 49(1):53-4. PubMed ID: 8091369
    [No Abstract] [Full Text] [Related]

  • 5. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
    Garg V, Jusko WJ.
    Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
    [Abstract] [Full Text] [Related]

  • 6. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML, Assael BM, Appiani AC, Edefonti A, Jusko WJ.
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [Abstract] [Full Text] [Related]

  • 7. [Comparative serum pharmacokinetics of prednisone and prednisolone methylsulfobenzoate after oral administration].
    Brion N, Pibarot ML, Atienza P, Robin P, Carbon C.
    Presse Med; 1988 Apr 02; 17(12):569-71. PubMed ID: 2967477
    [Abstract] [Full Text] [Related]

  • 8. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
    Wagner JG, DiSanto AR, Gillespie WR, Albert KS.
    Res Commun Chem Pathol Pharmacol; 1981 Jun 02; 32(3):387-405. PubMed ID: 7268190
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
    Frey BM, Seeberger M, Frey FJ.
    Transplantation; 1985 Mar 02; 39(3):270-4. PubMed ID: 3883592
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients.
    Chosidow O, Etienne SD, Diquet B, Vandermeersch V, Vu-Thi-My-Le C, Herson S, Puech AJ.
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep 02; 29(9):376-80. PubMed ID: 1938000
    [Abstract] [Full Text] [Related]

  • 13. [Systemic availability of prednisolone following oral administration of prednisone].
    Frey BM, Brandenberger AW, Frey FJ, Widmer HR.
    Pharm Acta Helv; 1984 Sep 02; 59(11):301-9. PubMed ID: 6514760
    [No Abstract] [Full Text] [Related]

  • 14. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
    Center SA, Randolph JF, Warner KL, Simpson KW, Rishniw M.
    Res Vet Sci; 2013 Aug 02; 95(1):225-30. PubMed ID: 23473553
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.
    Rollin C, Chosidow O, Diquet B, Dutreuil C, Herson S, Revuz J, Delchier JC.
    Eur J Clin Pharmacol; 1993 Aug 02; 44(4):395-9. PubMed ID: 8513854
    [Abstract] [Full Text] [Related]

  • 16. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M, Tempero K, Kirby M, Thompson J.
    Clin Ther; 2006 May 02; 28(5):715-24. PubMed ID: 16861093
    [Abstract] [Full Text] [Related]

  • 17. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW, Summerskill WH, Go VL.
    Gastroenterology; 1977 May 02; 72(5 Pt 1):910-3. PubMed ID: 849821
    [Abstract] [Full Text] [Related]

  • 18. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M, Chang S, Hellriegel ET.
    Clin Ther; 2009 Jan 02; 31(1):108-14. PubMed ID: 19243711
    [Abstract] [Full Text] [Related]

  • 19. Effects of thyroid dysfunction on prednisolone and prednisone interconversion and disposition in the rat.
    Murata R, Haughey DB, Jusko WJ.
    Drug Metab Dispos; 1990 Jan 02; 18(4):403-8. PubMed ID: 1976060
    [Abstract] [Full Text] [Related]

  • 20. Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers.
    Uribe M, Casian C, Rojas S, Sierra JG, Go VL.
    Gastroenterology; 1981 Apr 02; 80(4):661-5. PubMed ID: 7202937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.